StatLab announces the acquisition of Scientific Device Laboratory (“SDL”), a Chicago-based manufacturer of printed diagnostic slides and a variety of consumables and kits for the anatomic pathology and microbiology markets. The addition of SDL to the StatLab family of businesses expands customer reach for both entities and provides a new U.S. research and development hub for the broader StatLab organization.
“The acquisition of SDL provides a terrific opportunity to expand our presence in the microbiology market and increase the reach of StatLab products into new customer segments and regions through SDL’s current channels,” said Sung-Dae Hong, CEO of StatLab. “Together with SDL’s founder, Dr. Lipton, our team is looking forward to accelerating product development and innovation, while continuing to serve existing customers by scaling SDL operations through the commercial and manufacturing resources that StatLab can offer.”
Dr. Stewart Lipton founded SDL over 40 years ago after recognizing the need for customized clinical diagnostic products as a lab director at a major Chicago hospital. SDL manufactures customized products for OEMs, hospitals, and university laboratories, with a focus on printed diagnostic slides, control slides, and sample preparation products including mycobacterial test kits.
StatLab Executive Chairman Joe Bernardo added, “SDL is a unique acquisition for us; in conjunction with our newly added glass-slide manufacturing site in Germany, we are able to better service the existing customers of both StatLab and SDL through a dual-continent footprint for both glass manufacturing and R&D. This exemplifies the strength of our strategic differentiation through diverse manufacturing capabilities.”
“This decision to combine forces with StatLab will be transformative for our business,” SDL founder Dr. Stewart Lipton remarked. “Through scaling and optimizing the manufacturing of our core products, and by empowering us to focus on additional research to create new, innovative products, this transaction builds on SDL’s legacy of solving problems for our customers.”
Dr. Lipton will continue in his leadership role at the SDL manufacturing site in the near-term, and as StatLab continues to grow, he will shift focus to R&D and innovation as the combined company further scales its operations.
Arakelian and Associates LLC served as exclusive financial advisor to Scientific Device Laboratory on this transaction.
About Scientific Device Laboratory
SDL has been solving problems for clinical laboratories for over 40 years, supplying hospitals, universities and OEM customers with control slides, reagents, diagnostic sample preparation products, and more to support clinical testing in the microbiology and histology markets.
